Get started
Work

Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430

Year: 2008
Type: article
DOI: 10.1097/jto.0b013e318187494a
Authors: Thomas E. Stinchcombe, Ann M. Mauer, Lydia D. Hodgson, James E. Herndon, Thomas J. Lynch, Mark R. Green, Everett E. Vokes
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of Chicago Medical Center, Duke Medical Center, Massachusetts General Hospital, University of California San Diego
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
Funders: Massachusetts General Hospital, Ohio State University, Syracuse University, Wake Forest University, University of Missouri, University of Minnesota, Dartmouth College, University of South Carolina, University of North Carolina at Chapel Hill, Norris Cotton Cancer Center, State University of New York Upstate Medical University, National Cancer Institute
Awards: G10814802, WUMC Cancer and Leukemia Group B, G1689128559, G199746015, G20154349, G211333722, G220937036, G237383067, G260759372, Cancer and Leukemia Group B, G2647518335, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Cancer and Leukemia Group B, G739544170, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, G877081928, G877907214, G926666752, G973482110
OpenAlex ID: W2051725456
FWCI:
Cites: 29
Cited by: 2
Related to: 10